Liberant is indicated for the removal of fresh, soft emboli or thrombi from the vessels of the peripheral arterial and venous ...

Medtronic announced the first commercial use of the Liberant thrombectomy system, which is indicated for the removal of fresh, ...

Medtronic reported that its new thrombectomy system, aimed at removing blood clots from the arms and legs, has begun its ...

This retrospective analysis compares the efficacy of three endovascular treatment modalities in the treatment of vascular access stenoses: 1) plain-balloon angioplasty + drug coated balloon ...

ST. PAUL, Minn.--(BUSINESS WIRE)--Cardiovascular Systems, Inc. (CSI ®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients ...

MIAMI BEACH, FL—Intravascular imaging deserves a larger role in peripheral vascular interventions, according to a newly released consensus opinion of leaders spanning the many specialties involved in ...

Medical device company, Cardiovascular Systems (CSI), has purchased a line of peripheral support catheters from Utah-based WavePoint Medical, a medical device development company. The financial terms ...

Abbott Laboratories ABT recently announced the acquisition of Walk Vascular, LLC -- a commercial-stage medical device company with a minimally-invasive mechanical aspiration thrombectomy system. The ...

New U.S. guidelines emphasize treating peripheral artery disease (PAD) as a critical warning sign for overall cardiovascular ...

Holiday Heart Syndrome is a term coined by researchers to describe the regular increase in AF cases in December and January.